Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EVI2B |
| Upstream (Parents) |
|---|
| (<<) CYTIP → EVI2B |
| (<<) CD48 → EVI2B |
| (<<) CD53 → EVI2B |
| (<<) ARHGAP15 → EVI2B |
| Downstream (Children) |
|---|
| EVI2B → ADAM28 (>>) |
| EVI2B → P2RY13 (>>) |
| EVI2B → HLA-DOA (>>) |
| EVI2B → CYBB (>>) |
| EVI2B → ITGA4 (>>) |
| EVI2B → IL18 (>>) |
| EVI2B → PLEK (>>) |
| EVI2B → SAMSN1 (>>) |
| EVI2B → HLA-DMB (>>) |
| EVI2B → CD53 (>>) |
| EVI2B → RNASE6 (>>) |
| EVI2B → NPL (>>) |
| EVI2B → C7orf23 (>>) |
| EVI2B → ARHGAP15 (>>) |
